Elevance Health, Inc.·4

Jun 12, 4:12 PM ET

Dixon Robert L JR 4

4 · Elevance Health, Inc. · Filed Jun 12, 2026

Research Summary

AI-generated summary of this filing

Updated

Elevance Health (ELV) Director Robert L. Dixon Jr. Sells 151 Shares

What Happened
Robert L. Dixon Jr., a director of Elevance Health (ELV), reported an open-market sale of 151 shares on 2026-06-11 at $401.77 per share, producing proceeds of approximately $60,667. This was a disposal (sale) rather than a purchase.

Key Details

  • Transaction date: 2026-06-11
  • Transaction type/code: Open-market sale (S)
  • Shares sold: 151 at $401.77 each; proceeds ≈ $60,667
  • Form filed: accession 0001524849-26-000004, filed 2026-06-12 (timely; within two business days)
  • Shares owned after transaction: not provided in the information supplied — check the full Form 4 for "Amount Owned" if needed
  • Footnotes/plan: no 10b5-1 plan, tax-withholding, or other special footnotes reported in the supplied data

Context
Insider sales are common and can reflect many personal or tax-related reasons; they do not by themselves indicate the company’s outlook. Purchases generally carry clearer bullish signals for investors. For full details, review the Form 4 filing (accession 0001524849-26-000004) on the SEC EDGAR site.

Insider Transaction Report

Form 4
Period: 2026-06-11
Transactions
  • Sale

    Common Stock

    2026-06-11$401.77/sh151$60,66710,734 total
Signature
/s/ Kathleen S. Kiefer, Attorney in fact|2026-06-12

Documents

1 file
  • 4
    wk-form4_1781295167.xmlPrimary

    FORM 4